Tag: pharma research

Pharma Market | FDA’s approval to Pfizer’s Zirabev; Launch of Century Therapeutics; Imbruvica’s recommendation from CHMP

Business Consultant, DelveInsight's Drug Report, Notizia, Pharma Consultant, The Business Cocktail

Pfizer’s Zirabev gets FDA nod for the treatment of five types of cancer The US FDA has approved Zirabev (bevacizumab-bvzr), a drug...

Read More

Notizia

Business Consultant, Notizia, Pharma Consultant

Axovant rely on new gene therapy, Rise in Shares  Roivant Neuro Company has licensed Oxford Biomedica’s gene therapy OXB-102, now...

Read More

STAT INHIBITORS- Highly active Pipeline

Articles, Business Consultant, Pharma Consultant

Signal Transducer and Activator of Transcription (STAT ) is a family of cytoplasmic transcription factors comprising of 7 members-STAT1,...

Read More

Celiac Disease – Intestinal damage of Gluten

Articles, Business Consultant, Pharma Consultant

Celiac Disease (Gluten-Sensitive Enteropathy) is a chronic, autoimmune, inflammatory disease of the small intestine characterized by damage...

Read More

Meeting the Unmet: Nonalcoholic Steatohepatitis (NASH)

Articles, Business Consultant, Pharma Consultant

NASH is defined as the most common form of Nonalcoholic fatty liver disease (NAFLD). The disease is characterized by a spectrum of symptoms...

Read More

The Business Cocktail : Latest Pharma deals

Business Consultant, Pharma Consultant, The Business Cocktail

Ionis pharmaceuticals recently licensed-out its antisense drug to AstraZeneca in deal total worth up to USD 330 million Ionis...

Read More
Close